Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

Takashi Shimada, S. Mizutani, Takanori Muto et al. · Proceedings of the National Academy of Sciences · 2001 · 1.5K citations · Full text

Medicine, Oncology, Pathobiology +17

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson et al. · New England Journal of Medicine · 2003 · 920 citations · Full text

Medicine, Endocrinology, Genetics +15

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

Tobias E. Larsson, Ulf Nisbeth, Östen Ljunggren et al. · Kidney International · 2003 · 690 citations

Medicine, Endocrinology, Nephrology +12

Primer on the metabolic bone diseases and disorders of mineral metabolism.

M. Laurence · Journal of Bone and Joint Surgery - British Volume · 2000 · 684 citations

Medicine, Endocrinology, Orthopedic Surgery +14

Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia

Y. Yamazaki, Ryo Okazaki, Minako Shibata et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 675 citations

Medicine, Endocrinology, Pathobiology +14